Skip to main content
    A

    Alignment Healthcare LLC (ALHC)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NASDAQ

    $7.47
    +0.11 (+1.49%)

    Market Cap: $1.54B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Alignment Healthcare LLC (ALHC) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Alignment Healthcare LLC (ALHC) to earn $0.27 per share in the fiscal year ending Dec 31, 2026, on revenue of $5.26B. Of 15 analysts, 9 rate the stock Buy or Strong Buy, 6 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 4 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 15 ratings average 2.20, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 60% of the ratings.

    RatingAnalystsShare
    Strong Buy320.0%
    Buy640.0%
    Hold640.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    15

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 107.4% and revenue estimates rise 24.9%.

    Fiscal year ending Dec 31, 2026
    $0.27
    EPS consensus, revenue $5.26B
    Fiscal year ending Dec 31, 2027
    $0.56
    EPS consensus, revenue $6.57B
    Next report
    Feb 24, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.27$0.24 to $0.294$5.26B$5.25B to $5.31B11
    Dec 31, 2027$0.56$0.45 to $0.694$6.57B$6.42B to $6.75B13

    Quarterly Estimates

    The EPS consensus rises from -$0.20 for the quarter ending Dec 31, 2026 to $0.15 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.20-$0.29 to -$0.0117$1.36B$1.29B to $1.45B15
    Mar 31, 2027$0.15$0.13 to $0.163$1.56B$1.53B to $1.61B8

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 0 upward and 5 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202604
    Quarter ending Mar 31, 202701

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 46.0% from $0.50.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$0.27$0.45$0.50$0.50$0.50-46.5%
    Fiscal year ending Dec 31, 2027$0.56$0.65$0.75$0.75$0.75-26.2%
    Quarter ending Mar 31, 2027$0.15$0.19$0.19$0.19$0.19-24.1%

    Frequently Asked Questions About ALHC

    What is the ALHC stock forecast?

    Consensus analyst estimates put Alignment Healthcare LLC's EPS at $0.27 for the fiscal year ending Dec 31, 2026, on revenue of $5.26B. The consensus rating from 15 analysts is Buy.

    How do analysts rate ALHC stock?

    Of 15 analysts covering Alignment Healthcare LLC, 3 rate it Strong Buy, 6 Buy, 6 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from ALHC next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.27, with estimates from $0.24 to $0.29 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.56, with estimates from $0.45 to $0.69 from 4 analysts.

    What revenue do analysts expect from Alignment Healthcare LLC next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $5.26B, with estimates from $5.25B to $5.31B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $6.57B, with estimates from $6.42B to $6.75B.

    How many analysts cover ALHC?

    15 analysts rate Alignment Healthcare LLC stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.